Cargando…
Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
BACKGROUND: The development of a successful new tuberculosis (TB) vaccine would circumvent many limitations of current diagnostic and treatment practices. However, vaccine development is complex and costly. We aimed to assess the potential cost effectiveness of novel vaccines for TB control in a sub...
Autores principales: | Tseng, Chia-Lin, Oxlade, Olivia, Menzies, Dick, Aspler, Anne, Schwartzman, Kevin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039588/ https://www.ncbi.nlm.nih.gov/pubmed/21269503 http://dx.doi.org/10.1186/1471-2458-11-55 |
Ejemplares similares
-
Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
por: Jacquet, Vary, et al.
Publicado: (2006) -
Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015) -
Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2021) -
Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010) -
Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)